Loading...
Downregulation of PUMA underlies resistance to FGFR1 inhibitors in the stem cell leukemia/lymphoma syndrome
Resistance to molecular therapies frequently occur due to genetic changes affecting the targeted pathway. In myeloid and lymphoid leukemias/lymphomas resulting from constitutive activation of FGFR1 kinases, resistance has been shown to be due either to mutations in FGFR1 or deletions of PTEN. RNA-Se...
Saved in:
| Published in: | Cell Death Dis |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Nature Publishing Group UK
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7576156/ https://ncbi.nlm.nih.gov/pubmed/33082322 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41419-020-03098-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|